SalivaDirectTM: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
| Speaker: Dr. Anne Wyllie, Epidemiologist, Yale School of Public Health
Highlights • Flexible, extraction-free method to detect SARS-CoV-2 and enable testing of a greater number of individuals • Widespread testing for individuals aged K-12, which has proven particularly difficult during the pandemic • Benefits of SalivaDirect as a procotol vs as a testing kit |
More Information on UltraPlex 1-Step ToughMix: